Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism PSMB8 inhibitors(proteasome 20S subunit beta 8 inhibitors), PSMB9 inhibitors(proteasome 20S subunit beta 9 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | 02 Oct 2018 | |
Autoimmune Diseases | Preclinical | US | 02 Oct 2018 | |
Autoimmune Diseases | Preclinical | US | 02 Oct 2018 |